<DOC>
	<DOCNO>NCT01179880</DOCNO>
	<brief_summary>The safety pharmacokinetics topical application E6005 ointment compare vehicle evaluate Japanese male patient atopic dermatitis . Additionally , efficacy topical application E6005 ointment explore Japanese male patient atopic dermatitis .</brief_summary>
	<brief_title>A Study E6005 Japanese Patients With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Inclusion criterion ; Japanese adult male patient confirm diagnosis atopic dermatitis accord `` Guidelines Management Atopic Dermatitis '' Japanese Dermatological Association . Patients evaluable typical eczema back ( posterior trunk ) . Patients whose age equal 20 less 65 time treatment provide write informed consent . Exclusion criterion ; Patients complicate eye symptom ( e.g. , cataract , retinal detachment ) , Kaposi varicelliform eruption , molluscum contagiosum impetigo contagiosa . Patients severe allergy anaphylactic shock , anaphylactic reaction anaphylactoid reaction allergy/hypersensitivity E6005 excipients . Patients receive concomitant ethical drug phototherapy within 14 day prior Baseline . Subjects allow use external steroid tacrolimus ointment 8 day Baseline bland emollient free medicinal property ( e.g. , white petrolatum ) throughout study period . Patients infection require hospitalization intravenous/oral treatment antibiotic/antiviral/antifungal drug ( ) within 28 day prior Baseline . Patients malignancy , lymphoma , leukemia , lymphoproliferative disorder , dose include skin cancer ( e.g. , squamous cell carcinoma basal cell cancer ) completely remove metastasize 5 year .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Dermatitis</keyword>
	<keyword>Atopic</keyword>
</DOC>